Michael Allgäuer

5-year results of accelerated partial breast irradiation using sole interstitial multicatheter brachytherapy versus whole-breast irradiation with boost after breast-conserving surgery for low-risk invasive and in-situ carcinoma of the female breast: a randomised, phase 3, non-inferiority trial

Vratislav Strnad, Oliver J. Ott, Guido Hildebrandt et al. · The Lancet · 2015 · 656 citations

Medicine, Oncology, Radiation Oncology +16

Randomized Phase II Trial of Chemoradiotherapy Plus Induction or Consolidation Chemotherapy as Total Neoadjuvant Therapy for Locally Advanced Rectal Cancer: CAO/ARO/AIO-12

Emmanouil Fokas, Michael Allgäuer, Bülent Polat et al. · Journal of Clinical Oncology · 2019 · 540 citations · Full text

Medicine, Oncology, Surgery +17

Chemoradiotherapy Plus Induction or Consolidation Chemotherapy as Total Neoadjuvant Therapy for Patients With Locally Advanced Rectal Cancer

Emmanouil Fokas, Anke Schlenska‐Lange, Bülent Polat et al. · JAMA Oncology · 2021 · 354 citations · Full text

Medicine, Surgery, Gastrointestinal Oncology +13

Comprehensive Genomic and Transcriptomic Analysis for Guiding Therapeutic Decisions in Patients with Rare Cancers

Peter Horak, Christoph Heining, Simon Kreutzfeldt et al. · Cancer Discovery · 2021 · 285 citations

Medicine, Molecular Genetics, Oncology +17

Late side-effects and cosmetic results of accelerated partial breast irradiation with interstitial brachytherapy versus whole-breast irradiation after breast-conserving surgery for low-risk invasive and in-situ carcinoma of the female breast: 5-year results of a randomised, controlled, phase 3 trial

Csaba Polgár, Oliver J. Ott, Guido Hildebrandt et al. · The Lancet Oncology · 2017 · 255 citations

Medicine, Oncology, Radiation Oncology +17